Genetic Analysis

Spanish Study Identifies New Mutations for Fabry Disease
Research & Development Spanish Study Identifies New Mutations for Fabry Disease

The diagnostic landscape for rare lysosomal storage disorders has undergone a significant transformation recently as genomic researchers in Spain uncovered several previously unknown genetic variations responsible for Fabry disease. Rare metabolic conditions often remain shrouded in diagnostic

Mexican Men With Advanced Prostate Cancer Have Actionable Mutations
Research & Development Mexican Men With Advanced Prostate Cancer Have Actionable Mutations

A groundbreaking cross-sectional study at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán has unveiled critical genetic insights that could redefine the standard of care for Mexican men diagnosed with stage IV prostate cancer. Historically, the genomic landscape of prostate

How Is Digital Data Transforming Healthcare in Rwanda?
Tech & Innovation How Is Digital Data Transforming Healthcare in Rwanda?

Rwanda’s journey toward a modernized healthcare system represents one of the most significant public health transformations in East Africa, moving from a landscape of manual logs to a sophisticated digital ecosystem. For many years, the nation successfully navigated complex health challenges,

MicroRNA Markers Linked to Cancer Muscle Wasting in Dogs
Research & Development MicroRNA Markers Linked to Cancer Muscle Wasting in Dogs

Introduction Recent veterinary breakthroughs suggest that the silent deterioration of muscle mass in aging canines might finally have a detectable genetic signature that identifies early signs of physical decline. This syndrome, known as cachexia, often acts as a shadow to malignant tumors,

Lung Cancer Shows Major Sex-Based Protein Differences
Research & Development Lung Cancer Shows Major Sex-Based Protein Differences

The landscape of modern oncology is currently undergoing a transformative shift toward a more granular understanding of how individual biological factors influence disease pathology and treatment outcomes. For years, medical research often operated under a generalized framework, but recent evidence

How Will the Dark Genome Transform Personalized Oncology?
Tech & Innovation How Will the Dark Genome Transform Personalized Oncology?

Scientists have spent decades meticulously mapping the two percent of the human genome that codes for proteins, yet the remaining ninety-eight percent, often dismissed as "junk DNA," is proving to be the most critical frontier in modern oncology. This vast, unexplored territory, now commonly

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later